Haig P. Bozigian, Chief Development Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 9,092 shares at $113.79 ($1.1M) on 2021-02-05, disclosed to the SEC on 2021-02-09.
Seasonal sale ($1.1M) by Chief Development Officer — this insider has traded NBIX in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $113.79 | 704 | $80K | 7.6% |
| 2 | $113.79 | 704 | $80K | 7.6% |
| 3 | $116.78 | 1,395 | $163K | 15.4% |
| 4 | $116.78 | 1,395 | $163K | 15.4% |
| 5 | $116.79 | 1,623 | $190K | 17.9% |
| 6 | $116.79 | 1,623 |
| $190K |
| 17.9% |
| 7 | $116.85 | 824 | $96K | 9.1% |
| 8 | $116.85 | 824 | $96K | 9.1% |
| Total | $116.33 avg | 9,092 | $1.1M | 100% |
| Filing → |
| NBIX | SELL | 2020-05-14 | $14.2M | — | Filing → |
| NBIX | SELL | 2020-04-28 | $385K | — | Filing → |
| NBIX | SELL | 2020-02-11 | $335K | — | Filing → |